Pierre joined Amadeus Capital Partners in 2012 and leads early stage Health & Bio investments. He is on the boards of Inotec, Ori Biotech, PhoreMost, Quibim, Doctify, V7 and oversees our investments in Congenica, Lumeon and Organox.
Pierre has over a decade of entrepreneurial experience, having built and managed the growth of several life science businesses in Asia and Europe, from population genomics to medical nutrition.
Pierre speaks French and English.
More from Pierre
Blog: 9th January 2020
Blog: 18th December 2019